天海防务 reported revenue of ¥2.24B for the period ended 2026-06-30, +21.3% year on year. Net income was ¥0.18B, a 8.2% net margin on a 21.3% gross margin. The largest revenue line is 船海工程设计建造总承包业务 at 91% of the total. Free cash flow for the period was ¥-0.07B.
| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥2.24B | +21.3% |
| Gross profit | ¥0.48B | — |
| Operating income | ¥0.24B | — |
| Net income | ¥0.18B | +45.0% |
| Gross margin | 21.3% | Net margin 8.2% |
| Revenue Q/Q | +19.9% | — |
| Segment | Revenue | Share |
|---|---|---|
| 船海工程设计建造总承包业务 | ¥2.04B | 91.2% |
| 船海工程设计技术服务业务 | ¥0.06B | 2.5% |
| 能源业务 | ¥0.05B | 2.2% |
| 其他产品收入 | ¥0.04B | 1.8% |
| 防务装备及产品业务 | ¥0.03B | 1.3% |
| 其他(补充) | ¥0.01B | 0.5% |
| 船舶租赁收入 | ¥0.01B | 0.5% |
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥1.76B | 78.7% |
| R&D | ¥0.03B | 1.3% |
| SG&A | ¥0.20B | 8.8% |
| Tax & other | ¥0.06B | 2.6% |
| Item | Amount |
|---|---|
| Total assets | ¥6.65B |
| Total liabilities | ¥4.09B |
| Shareholders' equity | ¥2.56B |
| Equity / assets | 38.6% |
| Operating cash flow | ¥-0.06B |
| Capital expenditure | ¥0.01B |
| Free cash flow | ¥-0.07B |
| Cash conversion (OCF / net income) | 31% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
安科生物 ・ ST豆神 ・ 鼎汉技术 ・ 华测检测 ・ 新宁物流 ・ 北陆药业 ・ 网宿科技 ・ 中元股份 ・ 硅宝科技 ・ ST银江 ・ 大禹节水 ・ 吉峰科技
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies